This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.


An e-newsletter about our work in vaccine uptake and access

Immunization Matters provides updates from PATH’s Center for Vaccine Innovation and Access (CVIA) on late-stage and licensed vaccines included in our portfolio as well as our work on health economics and optimization, operations research, and support to countries. It includes updates on our progress, partnerships, and specific activities.

This is one of two newsletters published by CVIA. To learn more about CVIA’s vaccine development work, see Moving the Needle.

Recent issues

November 2019

  • Pakistan introduces typhoid conjugate vaccine
  • Reflecting on 15+ years of edging out Japanese encephalitis
  • Protecting more girls with HPV vaccine
  • Rotavirus vaccines remain cost-effective in Gavi countries
  • Q & A with Bill Hausdorff
  • Parting shot
  • Resources and opportunities

July 2019

  • Solomon Islands launches national HPV vaccination program
  • "Why maternal immunization?" explained
  • Help defeat meningitis
  • Ghana's phased rollout of the first malaria vaccine
  • Parting shot
  • Resources and opportunities

March 2019

  • Consortium releases compilation of published evidence on single-dose HPV vaccination
  • India-made rotavirus vaccines expand global reach
  • Philippines introduces Japanese encephalitis vaccine
  • PATH participates in upcoming typhoid conference
  • Q & A with Laurie Werner
  • Resources and opportunities

November 2018

  • A new look for our newsletter
  • New rotavirus vaccine from India achieves WHO prequalification
  • BID celebrates the transformative power of data and country ownership
  • Maternal immunization gets a head start
  • Integrating advocacy and communications into vaccine introduction—Q & A with Yvette Collymore
  • Parting shot
  • Resources and opportunities

July 2018

  • PATH joins CEPI, vaccine manufacturer, to develop Nipah virus vaccine
  • VASE Conference raises importance of advocating for early-stage vaccine candidates
  • Q & A with Deborah Atherly
  • Activity update
  • Parting shot
  • Resources and opportunities

April 2018

  • WHO recommends typhoid conjugate vaccine
  • PATH celebrates prequalification of low-cost, India-made rotavirus vaccine
  • Vaccine by the numbers: A Q&A with Clint Pecenka
  • Difficult flu season highlights the importance of seasonal vaccine production
  • Parting shot
  • Resources and opportunities

December 2017

  • Keeping up the momentum on typhoid
  • New measles-rubella vaccine achieves licensure in India
  • New DefeatDD state-of-the-field report highlights progress and opportunities
  • Activity update
  • Parting shot
  • Resources and opportunities

September 2017

  • CVIA receives investment from Bill & Melinda Gates Foundation
  • New collaboration to advance maternal immunization
  • Synthesizing evidence on HPV vaccination schedules
  • Using data to close the immunization gap
  • Activity update
  • Parting shot
  • Resources and opportunities

June 2017

  • New global effort to take on typhoid launches in Kampala
  • Ghana, Kenya, and Malawi to implement the RTS,S malaria vaccine in WHO-led program
  • Building health economics capacity among immunization decision-makers in Eastern Europe
  • Q & A – HPV vaccines and preventing cervical cancer
  • Immunization shot
  • Resources and opportunities

March 2017

  • Rotavirus vaccine introductions: Progress in Asia and impact in Africa
  • Addis Declaration on Immunization endorsed by African Heads of State
  • PATH country director receives Presidential Award
  • Vaccine journal publishes special addition on immunization supply chains
  • Activity updates
  • Resources and opportunities

December 2016

  • Introducing our e-newsletter highlighting “Immunization Matters”
  • Malaria vaccine candidate moves toward pilot implementation
  • Unprecedented progress in advancing Japanese encephalitis vaccines
  • Commentary: Continuing PATH’s fight against rotavirus from development to delivery
  • Reaching the hardest to reach: Q & A with Jemberu Raya Soressa
  • Activity updates
  • Resources and opportunities